CompletedPhase 2NCT02219165

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study

Studying Staphylococcal toxemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospices Civils de Lyon
Principal Investigator
Etienne Javouhey
Service de réanimation pédiatrique, Hôpital Femme Mère Enfant, Groupement Hospitalier Est, 59 Boulevard Pinel, 69677 BRON, FRANCE
Intervention
Intravenous human immunoglobulin(drug)
Enrollment
30 enrolled
Eligibility
17 years · All sexes
Timeline
2015 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02219165 on ClinicalTrials.gov

Other trials for Staphylococcal toxemia

Additional recruiting or active studies for the same condition.

See all trials for Staphylococcal toxemia →

← Back to all trials